SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Adam Neumann-backed Canada Global buys 74 dunams in Miami for $70.5M

From the lab to the world: Challenges shaping the future of smart healthcare in Israel

Israeli government’s role in reviving high-tech: Travel, diplomacy, and AI investment

Sam Altman-backed Apex Security in advanced talks to be acquired by Varonis for up to $40M

Buzz

Most popular

Daily

Weekly

1

Sam Altman-backed Apex Security in advanced talks to be acquired by Varonis for up to $40M

2

"Everyone will be a manager" - what the world of work will look like with AI agents

3

Facial recognition firm Oosto, formerly AnyVision, sold for $125M after raising $352M

4

What went wrong at AnyVision? Lessons from a $352M flameout

5

Mitiga raises $30M Series B to defend cloud services from cyberattacks

Destiny

2 stories about Destiny

סוהיל פרסאד, מנכ"ל ומייסד דסטני Sohail Prasad

The Destiny Fund isn’t beating the system - it's upholding it

21.04.24|Viki Auslender

The Destiny Tech100 fund is the latest fund that claims to connect unqualified investors with the leading private tech companies, claiming to offer new opportunities to allow us all to invest in major companies like angel investors. This isn’t the reality

חממת גידול קנאביס בבריטניה

Cannabis Companies Therapix and Destiny to Merge

28.07.19|Adi Pick

The merged company will focus on Therapix's technology and assets pertaining to clinical-stage pharmaceutical applications of cannabis, and will include Destiny's genomics-based cannabis breeding techniques and development capabilities